대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

쿠에타핀 중단 후 전신통증을 동반한 불면을 호소하는 환자에 대한 길초근단 치험 1례

A Case of Insomnia with Pain after Discontinuation of Quetiapine Treated with Gilchogeun-dan

  • 이성욱 (경희대학교 대학원 임상한의학과) ;
  • 박호정 (경희대학교 대학원 임상한의학과) ;
  • 이다빈 (경희대학교 대학원 임상한의학과) ;
  • 조기호 (경희대학교 대학원 임상한의학과) ;
  • 문상관 (경희대학교 대학원 임상한의학과) ;
  • 정우상 (경희대학교 대학원 임상한의학과) ;
  • 권승원 (경희대학교 대학원 임상한의학과)
  • Lee, Seong Wook (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Park, Hojung (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Lee, Da-Bin (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Cho, Ki-Ho (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Moon, Sang-Kwan (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Jung, Woo-Sang (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Kwon, Seungwon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
  • 투고 : 2022.04.09
  • 심사 : 2022.05.17
  • 발행 : 2022.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: This case report describes an 82-year-old man complaining of insomnia with pain after discontinuation of quetiapine. Methods: The patient was treated with the herbal extraction Gilchogeun-dan, and symptomatic improvement was assessed using the Korean version of the Pittsburgh Sleep Quality Index. Results: Following 28 days of Gilchogeun-dan treatment, the patient's symptoms improved. Conclusions: This case suggests that Gilchogeun-dan could be effective in treating insomnia with pain through central nervous depressant activity and analgesic effect.

키워드

참고문헌

  1. Choi HY, Lim WJ. Current Clinical Practice of Insomnia. Ewha Med J 2013;36(2):84-92. https://doi.org/10.12771/emj.2013.36.2.84
  2. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep Disorders and Sleep Effect in Parkinson's Disease. Mov Disord 1990;5(4):280-5. https://doi.org/10.1002/mds.870050404
  3. Ahn TB, Jeon BS. Sleep Disturbance and Sleep -related Disorders in Parkinson'Disease. Journal of the Korean Neurological Association 2002;20(4):365-72.
  4. Jahan I, Hauser RA, Sullivan KL, Miller A, Zesiewicz TA. Sleep disorders in Parkinson's disease. Neuropsychiatric Disease and Treatment 2009;5:535-40.
  5. Leeman AL, O'Neill CJ, Nicholson PW, Deshmukh AA, Denham MJ, Royston JP, et al. Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 1987;24(5):637-43. https://doi.org/10.1111/j.1365-2125.1987.tb03223.x
  6. Stocchi F, Barbato L, Nordera G, Berardelli A, Ruggieri S. Sleep disorders in Parkinson's disease. J Neurol 1998;245(1):S15-8.
  7. Medeiros CA, Carvalhedo de Bruin PF, Lopes LA, Magalhaes MC, de Lourdes Seabra M, de Bruin VM. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. J Neurol 2007;254(4):459-64. https://doi.org/10.1007/s00415-006-0390-x
  8. Carlos Juri, Pedro Chana, John Tapia, Carolina Kunstmann, Teresa Parrao. Quetiapine for Insomnia in Parkinson Disease, Results From an Open-Label Trial. Clin Neuropharmacol 2005;28(4):185-7 https://doi.org/10.1097/01.wnf.0000174932.82134.e2
  9. Monaca C, Ozsancak C, Jacquesson JM, Poirot I, Blond S, Destee A, et al. Effects of bilateral subthalamic stimulation on sleep in Parkinson's disease. J Neurol 2004;251(2):214-8. https://doi.org/10.1007/s00415-004-0305-7
  10. Lin CH, Liu CM, Huang WL. Quetiapine-induced hepatocellular damage. Psychosomatics 2012;53(6):601-2. https://doi.org/10.1016/j.psym.2012.06.001
  11. Nemeroff CB, Kinkead B, Goldstein J. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. J Clin Psychiatry 2002;63(13):5-11
  12. Seunghwa Shin, Su Hyun Kim. The Reliability and Validity Testing of Korean Version of the Pittsburgh Sleep Quality Index. Journal of Convergence for Information Technology 2020;10(11):148-55. https://doi.org/10.22156/CS4SMB.2020.10.11.148
  13. Seo JG, Lee HW, Park SP, Kang KH. The Interrelations of Quality of Sleep, Depressive Symptoms, and Quality of Life in Idiopathic Parkinson's Disease. J Korean Sleep Res Soc 2014;11(1):11-5. https://doi.org/10.13078/jksrs.14003
  14. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, et al. International multicentre pilot study of the first comprehensive self-completed non motor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21(7):916-23. https://doi.org/10.1002/mds.20844
  15. Roychowdhury S, Forsyth DR. Sleep disturbance in Parkinson disease. Journal of Clinical Gerontology & Geriatrics 2012;3(2):53-61. https://doi.org/10.1016/j.jcgg.2012.04.002
  16. Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New Drugs for Insomnia: Comparative Tolerability of Zopiclone, Zolpidem and Zaleplon. Drug Safety 2003;26(4):261-82. https://doi.org/10.2165/00002018-200326040-00004
  17. 이시진. 국역본초강목. 서울:행림출판사. 1976.
  18. Park SM, Kim YK, Yu SA, Cho SW, Lee MH, Lim E, et al. Effects of Valerianae Radix et Rhizoma Methanol Extract on High-fat Dietinduced Hyperlipidemic Mice. J Korean Med Obes Res 2020;20(2):88-96. https://doi.org/10.15429/jkomor.2020.20.2.88
  19. Ross SM. Sleep Disorders : A Single Dose Administration of Valerian/Hops Fluid Extract (Dormeasan) is Found to be Effective in Improving Sleep. Holist Nurs Pract 2009;23(4):253-6. https://doi.org/10.1097/HNP.0b013e3181aed09d
  20. Leuschner J, Muller J, Rudmann M. Characterisation of the central nervous depressant activity of a commercially available valerian root extract. Arzneimittelforschung 1993;43(6):638-41.
  21. Zare A, Khaksar Z, Sobhani Z, Amini M. Analgesic Effect of Valerian Root and Turnip Extracts. World J Plast Surg 2018;7(3):345-50. https://doi.org/10.29252/wjps.7.3.345
  22. Park HJ, Yoo JH, Kwon JH, Lee SW. Literature Review of Randomized Clinical Trials Regarding Insomina. J of Oriental Neuropsychiatry 2013;24(3):201-10. https://doi.org/10.7231/JON.2013.24.3.201
  23. Monahan K, Cuzens-Sutton J, Siskind D, Kisely S. Quetiapine withdrawal:A systematic review. Australian & New Zealand Journal of Psychiatry 2021;55(8):772-83. https://doi.org/10.1177/0004867420965693